Cardinal Health, Inc.
NYSECardinal Health heads into the first full week of May under pressure, having shed 4.2% over the past week to close at $197, while the Street digests a mixed earnings signal and a wave of freshly cut price targets. The earnings read tells the story of a split tape. The Q3 fiscal-year result released May 1 delivered a modest next-day gain of 2.2%, a reasonable outcome given the stock…
Snapshot as of 6 May 2026
Cardinal Health heads into the first full week of May under pressure, having shed 4.2% over the past week to close at $197, while the Street digests a mixed earnings signal and a wave of freshly cut price targets. The…
Cardinal Health reports its Q3 2026 results today against an uncomfortable backdrop: the stock is down nearly 7% over the past month, trading at $192.88, and the mean analyst price target of $247 implies roughly 28%…
Cardinal Health reports Q3 fiscal 2026 results this morning — and for once, the pre-print setup tilts notably in the bulls' favour. The most telling move arrived Tuesday, when William Blair initiated coverage with an…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CAH — free to start on ORTEX.
Sign up for free →Open CAH on ORTEX